Growing community of inventors

Spring House, PA, United States of America

Rifat Pamukcu

Average Co-Inventor Count = 2.44

ph-index = 15

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 822

Rifat PamukcuGary A Piazza (57 patents)Rifat PamukcuGerhard J Sperl (22 patents)Rifat PamukcuKlaus Brendel (18 patents)Rifat PamukcuPaul Gross (18 patents)Rifat PamukcuKerstin B Menander (6 patents)Rifat PamukcuUlrich Ixkes (3 patents)Rifat PamukcuXiaojing Michael Wang (2 patents)Rifat PamukcuW Joseph Thompson (2 patents)Rifat PamukcuEwa Skopinska-Rozewska (2 patents)Rifat PamukcuHan Li (1 patent)Rifat PamukcuLaura Rae McCabe (1 patent)Rifat PamukcuLi Liu (1 patent)Rifat PamukcuJoseph M Lobacki (1 patent)Rifat PamukcuBing Zhu (1 patent)Rifat PamukcuRifat Pamukcu (74 patents)Gary A PiazzaGary A Piazza (58 patents)Gerhard J SperlGerhard J Sperl (24 patents)Klaus BrendelKlaus Brendel (21 patents)Paul GrossPaul Gross (19 patents)Kerstin B MenanderKerstin B Menander (8 patents)Ulrich IxkesUlrich Ixkes (3 patents)Xiaojing Michael WangXiaojing Michael Wang (11 patents)W Joseph ThompsonW Joseph Thompson (8 patents)Ewa Skopinska-RozewskaEwa Skopinska-Rozewska (2 patents)Han LiHan Li (11 patents)Laura Rae McCabeLaura Rae McCabe (4 patents)Li LiuLi Liu (3 patents)Joseph M LobackiJoseph M Lobacki (1 patent)Bing ZhuBing Zhu (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Cell Pathways (67 from 75 patents)

2. University of Arizona (7 from 972 patents)

3. Osi Pharmaceuticals, Inc. (3 from 118 patents)

4. Other (2 from 832,680 patents)

5. Michigan State University (1 from 1,415 patents)

6. Midway Pharmaceuticals, Inc (1 from 1 patent)

7. Fgn, Inc. (1 from 1 patent)


74 patents:

1. 10045949 - Managing osteoporosis with HMW PEG

2. 7115647 - Method of inhibiting neoplastic cells with indole derivatives

3. 6875575 - Diagnostic methods for neoplasia

4. 6869944 - Method for treating a patient with neoplasia by treatment with a platinum coordination complex

5. 6610854 - Substituted condensation products of N-benzyl-3-indenylacentamides with heterocyclic aldehydes for neoplasia

6. 6562830 - Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives

7. 6555547 - Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative

8. 6500610 - Methods for identifying compounds for inhibiting of neoplastic lesions, and pharmaceutical compositions containing such compounds

9. 6486158 - [4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia

10. 6486155 - Method of inhibiting neoplastic cells with isoquinoline derivatives

11. 6479520 - Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives

12. 6472420 - Method for treating a patient with neoplasia by treatment with a paclitaxel derivative

13. 6455703 - 1,3,6,-Trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia

14. 6440981 - Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones

15. 6432950 - Method for inhibiting neoplastic cells and related conditions by exposure to benzothienopyrimidine derivatives

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…